Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Arbutus Biopharma Corporation (ABUS) Institutional Ownership & Insider Trading

177 institutions reported holding Arbutus Biopharma Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ABUSArbutus Biopharma CorporationFollow ABUS — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
831.0M
P/E TTM
5.3
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

177 institutions held 71.1% of the shares. Across filers that reported both quarters, shares held changed +0.7%.

Increased+63New+32Decreased-38Closed-19

Largest moves, shares (millions)

Goldman Sachs Group+2.4MNomura Holdings+1.6MState Street+1.5MMorgan Stanley-8.2MAdage Capital Partners Gp-2.7MADAR1 Capital Management-1.9M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-17.0Sep 24+1.1Dec 24+8.3Mar 25+6.4Jun 25-0.2Sep 25+3.6Dec 25+17.1Mar 26+1.0Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26177141+0.7%63323819
Mar 26167139+15.1%44224429
Dec 25172122+3.0%48154314
Sep 25165118-0.1%46174715
Jun 25162118+5.7%60134113
Mar 25166112+8.1%4019449
Dec 24151104+1.1%48143610
Sep 24142101-16.1%42243310

Arbutus Biopharma Corporation — questions

Who owns Arbutus Biopharma Corporation stock?
177 institutions reported Arbutus Biopharma Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: Two Seas Capital LP (9.7%), MORGAN STANLEY (8.9%), Whitefort Capital Management, LP (8.0%).

Every figure on this page comes from Arbutus Biopharma Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.